Trends in Market Access

How Market Access has become a value powerhouse.

Market Access as a function has come a long way in the past two decades. No longer just a consultation in regards to payers but now as a function across the whole organization. 

eyeforpharma along with Lundbeck, Astellas and Takeda look at just how far Market Access has come along in the past twenty years. Whilst also delving into Pharma's need to build a transparent relationship with payers and also how innovative pricing schemes are a crucial step in delivering affordable healthcare. 

Please subscribe to view the analysis report